Cataract surgery volume is projected to reach 33 million procedures globally. The data shows that 95.4% of patients achieve 20/40 or better vision post-surgery. This article presents the latest statistics on outcomes, complications, and global access.
Key Takeaways
- 95.4% of patients achieve 20/40 or better uncorrected visual acuity post-surgery
- Endophthalmitis rate post-surgery is 0.03-0.2%
- US average Medicare reimbursement for cataract surgery $575 per eye in 2022
- In the United States, approximately 24.4 million Americans aged 40 and older have cataracts
- Phacoemulsification accounts for 95% of cataract surgeries in developed countries
Cataract surgery is highly common and typically restores vision for most patients quickly.
Related reading
01 · Category
Clinical Outcomes and Success Rates18 stats
01
95.4% of patients achieve 20/40 or better uncorrected visual acuity post-surgery
02
Refractive predictability within 0.5D of target in 78% of standard IOL cases
03
Patient-reported satisfaction rate is 92-95% at 6 months post-op
04
Improvement in contrast sensitivity by 1.5-2 lines on Pelli-Robson chart
05
Posterior capsule opacification (PCO) occurs in 20% within 5 years, treated with YAG laser in 10-15%
06
98% spectacle independence for distance with multifocal IOLs
07
Mean logMAR visual acuity improves from 0.6 pre-op to 0.1 post-op
08
85% of patients report improved quality of life scores (VFQ-25) by 20 points
09
Endothelial cell loss averages 8-15% at 6 months post-phaco
10
Toric IOLs achieve axis alignment within 10 degrees in 88% of cases
11
97% complication-free surgeries in low-risk patients under topical anesthesia
12
Glare disability reduces by 70% post-surgery in nuclear cataracts
13
92% achieve binocular 20/25 or better at 3 months
14
IOL power calculation accuracy (SRK/T formula) within 1D in 95%
15
75% reduction in fall risk post bilateral surgery in elderly
16
Stereoacuity improves to 100 seconds of arc in 60% post-op
17
96% of FLACS cases achieve primary outcome of effective phaco time < target
18
Posterior capsule clarity maintained in 85% at 2 years with hydrophobic IOLs
Interpretation
Clinical Outcomes and Success Rates Interpretation
While boasting impressive stats—like nearly all patients ditching distance glasses and most seeing dramatically better—modern cataract surgery is an artful blend of high probability science and low probability art, where the nearly certain wins of vision and satisfaction come with the small, managed chance of needing a quick laser tune-up.
02 · Category
Complications and Adverse Events19 stats
01
Endophthalmitis rate post-surgery is 0.03-0.2%
02
Posterior capsule rupture occurs in 1.1-2.5% of phacoemulsification cases
03
Toxic anterior segment syndrome (TASS) incidence 0.01-0.1% with proper protocols
04
Corneal edema resolves in 95% within 1 week, affecting 5-10% initially
05
Iris prolapse rate 0.5% in microincision surgery
06
Cystoid macular edema (CME) post-op in 1-2%, higher 5% in diabetics
07
Vitreous loss in 0.5-1.2% of cases
08
IOL dislocation rate 0.2-1% within first year
09
Wound leak requiring suture 0.3%
10
Retinal detachment risk increases 2-5 fold post-surgery, incidence 0.7-1.3%
11
Infection rate reduced to 0.01% with intracameral cefuroxime
12
Hyphema in 1-2% with complicated cataracts
13
Ptosis post-op in 5-15%, resolves in 80%
14
Bullous keratopathy in 0.2% long-term
15
Elevated IOP >30mmHg in 5% day 1 post-op
16
Suprachoroidal hemorrhage 0.05-0.1% in high-risk patients
17
Dysphotopsia with multifocal IOLs in 5-10%
18
Zonal IOL opacification rare, <0.1%
19
Reoperation rate for complications 1.5-2.5%
Interpretation
Complications and Adverse Events Interpretation
While the odds are overwhelmingly in your favor, cataract surgery is a masterclass in precision where the stakes are measured in fractions of a percent, and the surgeon's skill is your best defense against a long but thankfully rare menu of potential complications.
03 · Category
Economic and Healthcare Utilization15 stats
01
US average Medicare reimbursement for cataract surgery $575per eye in 2022
02
Global cataract surgery market valued at $8.5 billion in 2023, projected to $12.2B by 2030
03
Patient out-of-pocket costs average $1,200for premium IOLs in US
04
Annual cataract surgeries in US: 4 million, generating $10B revenue
05
Cost-effectiveness ratio $2,500per QALY gained for cataract surgery
06
In India, MSICS costs $20-50 per surgery vs $200 for phaco
07
Medicare Part B covers 80% of allowable charges, avg $3,000 total cost
08
FLACS adds $1,000-1,500 to procedure cost
09
60% of surgeries outpatient, reducing hospital costs by 40%
10
Lifetime cost savings from preventing blindness: $177,000per patient
11
IOL market share: 45% hydrophobic acrylic, $3B annual sales
12
UK NHS cataract wait times cost £200M/year in lost productivity
13
Bilateral simultaneous surgery saves 20-30% costs, underused at 5% rate
14
High-volume centers: surgery cost $800vs $1,500 low-volume
15
Global south: surgery rate 1,000/ million vs 10,000/million in north, cost disparity driver
Interpretation
Economic and Healthcare Utilization Interpretation
The cataract surgery industry reveals a stark global irony: while it's celebrated as medicine's most cost-effective procedure, its financial architecture ensures that in wealthy nations, patients still pay a small fortune for clear vision, whereas in developing countries, the price of sight remains tragically out of reach for millions.
More related reading
04 · Category
Prevalence and Incidence20 stats
01
In the United States, approximately 24.4 million Americans aged 40 and older have cataracts
02
Globally, cataracts are responsible for 51% of world blindness, affecting about 20 million people
03
The prevalence of cataracts increases with age, reaching 68.3% in those 80 years and older in the US
04
In Europe, the age-standardized prevalence of cataracts is 17.2% for men and 20.8% for women aged 65+
05
India reports over 7 million cataract surgeries annually, with a backlog of untreated cases estimated at 6.8 million
06
Among US Hispanics/Latinos aged 50+, cataract prevalence is 53% compared to 32% in non-Hispanic whites
07
In Australia, 2.2 million people over 50 have cataracts, projected to rise to 2.8 million by 2025
08
Cataract incidence rate is 21.6 per 1,000 person-years in US adults over 65
09
In China, cataract prevalence is 58.6% in rural populations aged 50+
10
UK data shows 35% of those aged 65-74 and 70% over 75 have cataracts
11
Posterior subcapsular cataracts prevalence is 5.9% in US adults 40-49 years, rising to 29.5% in 75+
12
In sub-Saharan Africa, cataract blindness prevalence is 1.02% in adults 50+
13
US Medicare data: 3.7 million cataract surgeries in 2019
14
Brazil reports cataract surgery rate of 20.5 per 10,000 population annually
15
Nuclear cataracts affect 18.5% of US adults aged 60-69
16
In Japan, prevalence of cataracts in 70+ is 80.2%
17
Global cataract backlog estimated at 96 million untreated cases needing surgery
18
Cortical cataracts prevalence: 12.3% in US 50-59 year olds
19
In Iran, cataract prevalence is 37.9% in rural elderly
20
South Korea: 25.2% prevalence in 65+ population
Interpretation
Prevalence and Incidence Interpretation
While the developed world sees cataracts as a routine nuisance of aging, with millions of surgeries performed annually, the sobering global backlog reveals a stark, treatable inequity where geography and access, not just biology, remain the primary drivers of blindness.
05 · Category
Surgical Procedures and Techniques18 stats
01
Phacoemulsification accounts for 95% of cataract surgeries in developed countries
02
Multifocal intraocular lenses (IOLs) used in 15-20% of premium cataract surgeries in the US
03
Femtosecond laser-assisted cataract surgery (FLACS) adoption rate is 8-10% in US practices
04
Average phacoemulsification surgery duration is 10-15 minutes per eye
05
Toric IOLs implanted in 25% of astigmatic cataract cases >1.0D
06
Manual small incision cataract surgery (MSICS) preferred in developing countries, comprising 70% of surgeries in India
07
Capsulorhexis size averages 5.5 mm in standard phacoemulsification
08
Endocapsular phacoemulsification with IOL implantation success rate 98.5% in high-volume centers
09
Use of ophthalmic viscosurgical devices (OVD) in 99% of modern cataract surgeries
10
Intracameral antibiotics like cefuroxime used in 60% of European surgeries to prevent endophthalmitis
11
Average incision size for microincision phaco is 2.2-2.8 mm
12
Hydrodissection performed in 92% of phaco cases to facilitate rotation
13
Monofocal IOLs used in 70-80% of all cataract surgeries worldwide
14
Bimanual irrigation/aspiration used post-phaco in 85% of cases
15
Pupil expansion devices employed in 5-10% of surgeries for small pupils
16
Acrylic IOLs preferred over PMMA in 95% of modern implants
17
Chop techniques (stop-chop) used in 40% of dense cataracts
18
Postoperative topical steroid use for 4 weeks in 90% of patients
Interpretation
Surgical Procedures and Techniques Interpretation
While we've nearly perfected the art of removing life's cloudy little annoyances with startling speed and success, our true surgical personality shines in the details—geographically tailored techniques, a meticulous buffet of lenses and lasers, and an almost universal embrace of the surgical goo, all in the noble pursuit of giving 98.5% of patients a clearer view of the world they'd been missing.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Ryan Townsend. (2026, February 13). Cataract Surgery Statistics. Gitnux. https://gitnux.org/cataract-surgery-statistics
MLA
Ryan Townsend. "Cataract Surgery Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/cataract-surgery-statistics.
Chicago
Ryan Townsend. 2026. "Cataract Surgery Statistics." Gitnux. https://gitnux.org/cataract-surgery-statistics.
Sources & references
21 datasets cited across this report · attribution is report-level